Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block for Pain After Lumbar Spine Fusion
NCT04588389Phase 3Terminated
- Sponsor
- University of Massachusetts
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ropivacaine in postoperative pain (3 arms), sponsored by University of Massachusetts. Primary endpoint: Opioid Consumption at 48 hours. Started Dec 2020; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04588389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588389.